Article Details
Retrieved on: 2021-02-16 12:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Unity Biotechnology (NASDAQ:UBX) was downgraded by equities researchers at Citigroup from a "neutral" rating to a "sell" rating in a report released ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here